1-310-598-5410 investor.relations@opiant.com
Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Science and Technology
    • Burden of Substance Use and Eating Disorders
    • The Science of Addiction
    • Opioid Antagonists
    • Nasal Spray Delivery Technology
    • Publications
    • Intellectual Property
  • Products and Pipeline
    • Pipeline Chart
    • Opioid Overdose Reversal
    • Alcohol Use Disorder
    • Eating Disorders
    • Heroin Vaccine
  • Investor Relations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • News Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financials & Filings
      • SEC Filings
      • Annual Reports & Proxy Statements
    • Investor Resources
      • Information Request
      • IR Contact
      • Email Alerts
  • Home
  • About Us

    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Science and Technology

    • Burden of Substance Use and Eating Disorders
    • The Science of Addiction
    • Opioid Antagonists
    • Nasal Spray Delivery Technology
    • Publications
    • Intellectual Property
  • Products and Pipeline

    • Pipeline Chart
    • Opioid Overdose Reversal
    • Alcohol Use Disorder
    • Eating Disorders
    • Heroin Vaccine
  • Investor Relations
    • Stock Information

      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • News Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financials & Filings

      • SEC Filings
      • Annual Reports & Proxy Statements
    • Investor Resources

      • Information Request
      • IR Contact
      • Email Alerts

Board of Directors

More Info

Roger Crystal, MD

Chief Executive Officer

More Info

Gabrielle A. Silver, MD

Lead Independent Director

More Info

Michael Sinclair, MD

Director

More Info

Craig Collard

Independent Director

More Info

Richard J. Daly

Independent Director

More Info

Ann MacDougall, JD

Independent Director

More Info

Thomas T. Thomas

Independent Director

About Opiant
Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapies to treat substance use and eating disorders.
Quick Links
About Us
Science and Technology
Products and Pipeline
Investor Relations
Contact
Opiant Pharmaceuticals
201 Santa Monica Blvd., Suite 500
Santa Monica, CA 90401
PHONE: 310-598-5410
info@opiant.com
investor.relations@opiant.com
© COPYRIGHT 2017 OPIANT PHARMACEUTICALS, INC   |  Disclaimer  |  Privacy Policy  |  Terms of Use